Press Releases

Tobias Leipold, CEO and Co-Founder, leaves eHealth-Tec GmbH

Betül Susamis Unaran leaves Zur Rose Group

Zur Rose Group AG: Shareholders approve all proposals

Zur Rose Group sees revenue perform as expected in the first quarter of 2022

Zur Rose Group AG publishes invitation to the Annual General Meeting of 28 April 2022
Ad hoc announcement pursuant to Art. 53 LR

Max Müller to be new CEO of TeleClinic, taking over from founder and former CEO Katharina Jünger

Zur Rose Group: Excellent starting position for e-prescriptions set up and ecosystem strategy successfully continued
Ad hoc announcement pursuant to Art. 53 LR

Zur Rose Group: steady growth in a volatile market environment

Zur Rose Group nominates Rongrong Hu as director

Zur Rose and the Swiss Association for the Blind and Visually Impaired make it easier for people with a visual impairment to take medication

Zur Rose Group successfully completed capital increase from authorised capital and sets placement price at CHF 290 per new share
Ad hoc announcement pursuant to Art. 53 LR

Zur Rose Group decides on capital increase from authorised capital and starts accelerated bookbuilding to make full use of increasing market opportunities
Ad hoc announcement pursuant to Art. 53 LR

eHealth-Tec achieves first place in the TOP 100 competition

Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes

Zur Rose Group: Board of Directors nominates Walter Oberhänsli as Chairman and appoints Walter Hess as new CEO
Ad hoc announcement pursuant to Art. 53 LR

Zur Rose Group continues to grow strongly
Ad hoc announcement pursuant to Art. 53 LR

Health app Well heralds the future of healthcare

Zur Rose Group accelerates growth in second quarter with revenue up 26 per cent
Ad hoc announcement pursuant to Art. 53 LR

No more paper: e-prescriptions are coming

Zur Rose Group strengthens Group Management: Madhu Nutakki to become Chief Technology Officer

Faster and more secure access to the gematik e-prescription with eHealth-Tec: Compatible software development kit for software providers

Annual General Meeting of Zur Rose Group AG: Shareholders approve all proposals

DocMorris expands management team: Dr. Ulrich Thomé is appointed Chief Strategy Officer

Zur Rose Group signals dynamic revenue development in the first quarter of 2021

Zur Rose Group AG publishes invitation to the Annual General Meeting on 29 April 2021

Introducing DocMorris Adipositas Care (Obesity Care), a digital hub empowering people with obesity to find relevant care for a better quality of life.

Zur Rose Group further extends European market leadership and successfully implements healthcare platform

DocMorris goes European: new branding for marketplaces in Spain and France

The Zur Rose Group accelerates growth

Zur Rose vindicated after court finds CEO Walter Oberhänsli not guilty

Collaboration between Zur Rose Group and Novo Nordisk: The Zur Rose Group and Novo Nordisk combine their expertise to improve the health journeys of people with obesity

TeleClinic builds on market leadership in telemedicine

The healthcare platform of the future: DocMorris+ is launched

Local Pharmacy Strengthening Act circumvents ECJ ruling

Zur Rose Group AG: Olaf Heinrich, Head Germany, is leaving the Zur Rose Group; his successor will be Walter Hess, Head Switzerland

New branding for a new vision: DocMorris

Zur Rose Group: gematik awards tender for specialist e-prescription service - Zur Rose subsidiary eHealth-Tec involved as partner to IBM

Allianz Care, CSS, Visana and Zur Rose Group in ground-breaking digital healthcare platform partnership

Zur Rose Group accelerates growth in third quarter 2020

Zur Rose and KPT together launch digital medicines assistant Medi+

Zur Rose Group reinforces European market leadership by rigorously implementing the growth and platform strategy

Zur Rose Group successfully concluded acquisition of the e-commerce and diabetes activities of Apotal Group

Zur Rose Group successfully concluded acquisition of TeleClinic

Zur Rose Group successfully completed capital increase from authorized capital and sets placement price

Zur Rose Group AG resolves on capital increase from authorized Capital

Zur Rose Group gives indications for half-year results

Zur Rose Group acquires TeleClinic, Germany's leading telemedicine provider

Zur Rose Group strengthens European market leadership through acquisition of mail-order and diabetes activities of Apotal Group

Zur Rose Group: Charges in connection with mail-order of non-prescription drugs and electronic prescribing

2020 Annual General Meeting of Zur Rose Group AG: Shareholders adopt all proposals

Zur Rose Group AG publishes adjusted proposal for the creation of authorized share capital and withdraws the agenda item relating to the creation of additional conditional capital for the Annual General Meeting 2020

Zur Rose Group starts 2020 with strong growth

Zur Rose Group AG publishes invitation to the Annual General Meeting on 23 April 2020

Zur Rose Group AG successfully completes the placement of CHF 175 million Convertible Bonds due 2025

Zur Rose Group AG launches CHF 150 million Convertible Bonds due 2025 with up to CHF 25 million increase option

COVID-19: Zur Rose is calling for an exception allowing the mail-orders for over-the-counter emergency, cold and flu medicines

Zur Rose Group maintains growth momentum

Zur Rose Group broadens its leadership structure and completes Group Management

Zur Rose Group posts 30 per cent growth in 2019

Zur Rose Group strengthens Group Management: Bernd Gschaider becomes Chief Operations Officer

Zur Rose Group: Purchase price payment for medpex acquisition completed early by earn-out settlement

Cooperation between Medbase and Zur Rose: The two joint ventures between Zur Rose and Medbase will commence operations at the start of the year

Zur Rose Group AG increases public bond to CHF 200 million

Cooperation between Migros and Zur Rose: Zur Rose and Migros open the first shop-in-shop pharmacy in French-speaking Switzerland

Zur Rose Group AG successfully issues a public straight bond of CHF 180 million

Zur Rose Group posts acceleration of growth in third quarter 2019

Zur Rose Group grows almost 30 per cent in the first half of 2019

Cooperation between Migros Group and Zur Rose: Zur Rose and Migros step up cooperation

Zur Rose shareholders adopt all proposals

Zur Rose Group AG publishes invitation to the Annual General Meeting of Shareholders on 23 May 2019

Zur Rose Group grows 28 per cent in the first quarter of 2019

The Zur Rose Group nominates three new board members

The Zur Rose Group accelerates growth

Zur Rose Group accelerates internationalisation

Change on the Board of Directors of the Zur Rose Group

Zur Rose Group realised its expansion goals in 2018 and grew by over 20 percent

Zur Rose Group: Acquisition of medpex successfully concluded

Zur Rose Group increases share capital

Zur Rose and the Swiss Association for the Blind and Visually Impaired make it easier for people with a visual impairment to take medication

Archive

Button open menu

Button close menu